Review:
Nothing can scare us quite as much as cancer. This disease, striking sometimes sensibly, sometimes arbitrarily, inspires despair and hopelessness to the same extent that its cure eludes us. Cancer researcher Mel Greaves illuminates what we know of its causes and the obstacles to research in Cancer: The Evolutionary Legacy. The subtitle is intriguing, and Greaves backs it up with a detailed examination of the evolutionary biology of cancer cells. It turns out that we can profitably think about cancer as a tool in the struggle for survival and reproduction among all the cells within a body. Losing regulatory genes might be great for reproducing individual cell lines, but in the long run, they are, of course, devastating to the organism as a whole. Greaves's personal, almost chatty style helps the nontechnical reader through some of the complicated immunological and genetic issues, and it also humanizes a topic that can easily overwhelm us with awe. Slipping back a few centuries, he explores the history of cancer and our attitudes toward it, then looks at how it has changed in recent years to become more widespread and better understood. Though Greaves is careful not to promise a cure just around the corner, his experience lends the writing an optimism that most readers will find refreshing. Though we're still at the mercy of this terrible disease, it's good to know we have more than just natural selection on our side. --Rob Lightner
About the Author:
Mel Greaves is Director of the Leukemia Research Fund Center at the Institute of Cancer Research, in London. The winner of several awards for cancer research, he lives in London.
"About this title" may belong to another edition of this title.